Effectiveness Study of Integrative Treatment for Pediatric Pneumonia

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Liaoning University of Traditional Chinese Medicine
• Collaborator: Beijing University of Chinese Medicine
• Treatments: Albuterol; Chlorpheniramine, phenylpropanolamine drug combination; Guaifenesin; Ibuprofen; Phenylpropanolamine; Ribavirin

Criteria

Inclusion Criteria:

• children, aged 6 months to 59 months old, diagnosed as pneumonia according to western medicine diagnostic criteria;

• diagnosed as TCM pneumonia with gasp-cough, meeting wind-heat blocking lungs pattern (feng re bi fei zheng), and phlegm-heat blocking lungs pattern (tan re bi fei zheng);

• disease progression within 72 hours;

• those whose guardians understood and assigned the informed consent;

Exclusion Criteria:

• emergency pneumonia;

• complicated with other Pulmonary Disorders attack other than pneumonia;

• complicated with primary disease of heart (congenital heart disease, myocarditis, et al), liver (ALT, and AST ≥ 1.5 times of normal value ceiling), kidney (BUN > 8.2mmol/L, or serum CR > 104 µmol/L, et al) and blood system (anemia), and those with psychopathy;

• allergic to interventional medications;

• those who are participating or have participated in other clinical trials in 3 months.